top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Cancer Nanomedicine
Cancer Nanomedicine
Autore Hoskins Clare
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (510 p.)
Soggetto topico Technology: general issues
Soggetto non controllato antibody drug conjugate (ADC)
PD-L1
tumor spheroid disruption
immune modulation
doxorubicin
graphene oxide
adsorption
cathepsin D
cathepsin L
anti-metastatic enzyme cancer therapy
nanoparticles
targeted delivery system
siRNA
osteopontin
mammary carcinoma
mesenchymal stem cells (MSCs)
TAT peptide
PLGA
paclitaxel
nano-engineered MSCs
orthotopic lung tumor model
intracranial glioma
immunotherapy
CPMV
viral nanoparticles
in situ vaccine
albumin nanoparticles
microbubble
ultrasound
theranostics
hepatocellular carcinoma
VX2 tumor
intra-arterial chemotherapy
lung cancer
nanomedicine
clinical status
cancer therapy
breast cancer
cell signaling
active targeting
passive targeting
EPR effect
oncogenes
nanoparticle
drug delivery
ligand
tumor targeting
biodistribution
Mesoporous silica nanoparticle
drug delivery system
target treatment
lanthanide metal
hyaluronic acid
hyaluronidase
drug combination
everolimus
dual-targeting
magnetic nanoparticles
monoclonal antibodies
nanostructured lipid carrier
platelet membrane
biomimicry
plasmonic photothermal therapy
gold nanorods
surgery
bleeding
dogs
cats
stimuli-responsive
DOX
SN38
CSCs
single-walled carbon nanotubes
chirality separation
NASH
drug-gene delivery
near IR hyperspectral imaging
plasmonics
copper
VEGF
glioblastoma
differentiated neuroblastoma
peptidomimetics
real-time quantitative polymerase chain reaction (qPCR)
actin
combinatorial therapy
anticancer and antibacterial activity
temoporfin
drug-in-cyclodextrin-in-liposome
hybrid nanoparticles
multicellular tumor spheroids
cyclodextrins
photodynamic therapy article
yet reasonably common within the subject discipline
antitumor strategy
biomimetic core–shell nanoparticles
NK cell-derived exosomes
folate receptor
albumin nanoparticle
microfluidic
cabazitaxel
polydopamine nanoparticles
size
cytotoxicity
iron affinity
FA-DABA-SMA
self-assembly
oncogenic proteins
intracellular disruption
folic receptor alpha
pancreatic cancer
parvifloron D
albumin
erlotinib
photodynamic therapy
lipid nanoparticles
tumor vectorization
verteporfin
ovarian carcinomatosis
spheroids
integrin
RGD peptide
cancer diagnosis
radiotherapy
hyperthermia therapy
biomimetic
nanocarrier
membrane-wrapped
cancer
targeted delivery
photothermal therapy
imaging
cancer nanomedicine
tumor microenvironment
nano–bio interactions
clinical translation
magnetic nanowires
magnetic hyperthermia
magnetic actuation
magnetic drug targeting
titanate nanotubes
gold nanoparticles
vectorization
colloidal stability
docetaxel
prostate cancer
mangiferin
anti-topoisomerase activity
extracellular vesicles
exosomes
chemico-physical functionalization
loading
translational medicine
nanotechnology: bioengineering
anacardic acid
mitoxantrone
targeted drug delivery
liposomes
melanoma
apoptosis
ascorbic acid
angiogenesis
epithelial-to-mesenchymal transition
hypoxia
immunosuppression
metabolism
nanotherapeutics
tumour microenvironment
DNA origami
liposome
remote loading
acute toxicity
organoids
magnetic silica-coated iron oxide nanochains
photothermal treatment
hyperthermia
collagen
cellular microenvironment
lymphadenectomy
magnetometer
sentinel lymph node dissection
SPION
superparamagnetic iron oxide nanoparticles
Vδ2 T cells
zoledronic acid
polymeric nanoconstruct
anti-tumor immunity
colorectal carcinoma
β-cyclodextrin nanosponges
BALB-neuT mice
brain tumours
glioma
blood brain barrier
polymeric nanoparticles
PEGylation
dioleoylphosphatidylethanolamine
poly(hydroxyethyl acrylate-co-allyl methyl sulfide) copolymer
folate
oxidation-sensitive release
cellular interaction
in vitro anti-cancer activity
triple negative breast cancer
organotin
mesoporous silica nanoparticles
MDA-MB-231
theranostic nanomaterials
nanobiotechnology
molecular imaging
nanosystems
nanomicelles
ovarian cancer
tumour targeting
chemotherapeutics
riboflavin
vitamin B2
nanomedicines
secondary structure
mixed micelle
pH responsive
targeted therapy
anti-cancer
shear stress
flow
in vitro
therapeutics
diagnostics
Immunotherapy
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557114703321
Hoskins Clare  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Drug Delivery of siRNA Therapeutics
Drug Delivery of siRNA Therapeutics
Autore Lamberti Gaetano
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (288 p.)
Soggetto topico Medicine
Soggetto non controllato oligonucleotide delivery
light-activated release
intracellular release
liposome
indocyanine green
drug co-delivery
methotrexate
siRNA
antitumor effect
mixed micelles
targeted delivery system
cationic liposome
folate
folate receptor
cationic cholesterol derivative
siRNA delivery
gene knockdown
tumor-targeting
VEGFA
VEGFR1
endoglin
peptide
angiogenesis
gene silencing
migration
proliferation
endothelial cells
RNAi therapeutics
amphiphilic dendrons
PAMAM dendrimers
self-assembling
nanovectors
covalent dendrimers
NABDs
liposomes
clinical trials
drug delivery
nanoparticle
carbonate apatite
ERBB2
AKT
breast cancer
ovarian cancer
polymer
lipid
delivery
poly(ethylene) imine
PEI
RNA
tyrosine-modification
tumor xenograft
magnetic nanoparticle
iron oxide
BCL2
BIRC5/survivin
oral cancer
aptamers
cancer
nanoparticles
STAT6
polyaspartamide
pegylation
polyamine
polyplexes
asthma
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557498903321
Lamberti Gaetano  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Role of Natural Bioactive Compounds in the Rise and Fall of Cancers : Volume 2
Role of Natural Bioactive Compounds in the Rise and Fall of Cancers : Volume 2
Autore Luparello Claudio
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (318 p.)
Soggetto topico Research & information: general
Biology, life sciences
Soggetto non controllato berberine
signaling pathways
oncogenic cascades
TRAIL
microRNAs
cancer therapy
colon cancer cells
ethanol
Nrf2
HO-1
ER stress
autophagy
MMPs
formononetin
cancer
preclinical models
cell signaling
angiogenesis
nobiletin
colorectal cancer
chemoprevention
bioactivities
experimental therapeutics
HDAC
multiple myeloma
oleacein
breast cancer
persistent organic pollutants
breast cancer risk
breast cancer prognostic
systematic review
carrageenan
invasion
metastasis
RacGAP1
radiotherapy
marine sponge
natural product
anticancer drug
oral cancer inhibition
phytochemicals
small organic agents
Piper eriopodon, alkenylphenols
human cancer cells
cell death
apoptosis
caspase-independent cell death
XIAP antagonists
XIAP-BIR3 domain
Calocedrus formosana
lung cancer
yatein
cell-cycle arrest
xenograft
isorhamnetin
G2/M arrest
ROS
AMPK
pancreatic cancer
epigallocatechin-3-gallate (EGCG)
gemcitabine
glycolysis
phosphofructokinase
natural polyphenols
anticancer activities
molecular mechanisms
Streptomyces
mangrove
anti-proliferative
colon cancer
epithelial mesenchymal transition
inflammation
malignant cancer
natural anti-inflammatory compounds
pro-resolving lipids
anticancer drugs
flavonoids
natural compounds
Xenopus laevis
AOM/DSS model
melanoma cells
nicotine
α9-nAChR
PD-L1
STAT3
gigantol
AKT
JAK/STAT
cancer stem cell
tumor maintenance
tumor density
proteomics
honokiol
anticancer
mechanism
signalling pathway
uterine sarcoma
fucoidan
isobolography
colchicine alkaloid
mesoporous silica nanoparticles
targeted delivery system
PD-1 immune checkpoint inhibitor and cancer immunotherapy
glucose transport
drugs
innate immunity
β-glucans
nutrition
immunotherapy
estrogen
estrogen receptor alpha
polyphenols
daidzein
daidzein metabolites
paclitaxel
breast cancer cells
obesity
renin-angiotensin system
eicosapentaenoic acid
adipocyte inflammation
olive leaf extract
oleuropein
Seahorse analysis
cancer metabolism
glycolytic markers
Malva pseudolavatera Webb &
Berthel
acute myeloid leukemia
reactive oxygen species
brain cancer
gliomas
schwannomas
malignant tumors of the peripheral nerve sheath (MPNST)
neurofibromas
bioavailability
nanoparticle-based delivery systems
natural bioactive compound
gallic acid
EGFR signaling
p53
EGCG
non-coding RNAs
anti-cancer drug
NSCLC
EGFR TKI
FASN inhibitors
resistance
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Role of Natural Bioactive Compounds in the Rise and Fall of Cancers
Record Nr. UNINA-9910557476303321
Luparello Claudio  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui